ArticleGastroenterology2021

Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer.

Akira Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.